Last updated on June 18th, 2026 at 01:33 pm
NAD+ therapy has become a common offering in detox and recovery programs because it targets the metabolic toll that addiction takes on the body: low cellular energy, strained mitochondria, and disrupted neurotransmitter systems. The idea is biochemical rather than behavioral, aiming to ease withdrawal, support early recovery, and clear the cognitive fog that can make sobriety feel out of reach.
The rationale is grounded in real biology. NAD+, short for nicotinamide adenine dinucleotide, is a coenzyme essential for turning nutrients into energy and for the enzymes that repair DNA and regulate neuroplasticity. That gives it a plausible route to blunting cravings and lifting mood during the hardest early days.
Plausible, however, is not the same as proven. Clinical reports are largely encouraging while rigorous randomized trials remain scarce, which is why NAD+ is best understood as an adjunct rather than a cure. This article explains how NAD+ is used, how it is administered, what the evidence supports, and where caution is warranted.
NAD+ is a coenzyme found in every cell, where its central job is shuttling electrons through the reactions that generate ATP, the body’s basic energy currency. Without enough of it, mitochondrial respiration stalls, and cells, including neurons, struggle to keep up with their normal workload.
Its role extends well beyond energy. NAD+ is also a substrate for sirtuins and PARP enzymes, molecular systems that repair DNA and manage oxidative stress. When NAD+ runs low, those repair processes slow down, leaving cells more vulnerable to damage at exactly the moment they need to recover.
Chronic substance use depletes NAD+ and stresses mitochondrial function. The brain, already adapted to the extra chemical inputs a drug provided, is suddenly asked to run demanding processes on a depleted energy supply. That shortfall contributes to the fatigue, cravings, and impaired decision-making of early abstinence.
This is the gap NAD+ therapy aims to close. By replenishing the coenzyme directly, the approach tries to restore the cellular energy and repair capacity that addiction eroded, giving the brain a steadier metabolic foundation from which to begin recovery.
Withdrawal places heavy demands on brain metabolism and neurotransmitter balance. Because NAD+ participates in the reactions that generate ATP and supports enzymes tied to dopamine and serotonin turnover, restoring it may reduce some of the anxiety, agitation, and craving that drive early relapse.
In practice, clinics use NAD+ during the acute phase to take the edge off symptoms and keep people engaged with the rest of their care. Delivered within a private, medically supervised detox, it is paired with standard symptom-directed treatment rather than used on its own, which is the safest way to approach the most fragile window of recovery.
Patients frequently describe improved energy, less irritability, and clearer thinking during or after a series of infusions. Those subjective gains have a plausible biochemical basis: as cellular energy returns, neurons can resume more normal signaling in reward and stress circuits.
The honest caveat is that most of this evidence is observational. The reports suggest benefit without proving it, so the reasonable stance is to use NAD+ to ease symptoms and improve engagement where it helps, while keeping expectations measured and tracking real outcomes over time.
There is a practical logic to using it early, as well. The first days of withdrawal are when many people disengage and return to use, so anything that reliably reduces fatigue and fog can improve the odds that someone stays long enough to benefit from counseling and medical care. Improving retention through that fragile window is a meaningful goal in its own right.
Detox is two tasks at once: clearing a substance and repairing the damage it left behind. NAD+ is involved in several of the processes that make the second task possible, which is why it is framed as a support for cellular recovery rather than a treatment in itself.
The most direct contribution is to energy. NAD+ shuttles electrons in the reactions of mitochondrial respiration, the cellular machinery that produces ATP. When the coenzyme is scarce, that machinery slows and neurons lose the fuel they need for neurotransmitter synthesis and synaptic regulation. Replenishing NAD+ helps mitochondria resume normal function, which clinically can translate into better energy and less of the physiological shock that makes early detox so brutal.
Beyond energy, NAD+ fuels sirtuins and PARP enzymes that repair DNA and manage the oxidative stress chronic use generates. When NAD+ is depleted, these repair and resilience pathways stall, leaving cells exposed to ongoing damage. Boosting the coenzyme reactivates them, supporting the slow molecular cleanup that has to happen for tissues, including brain tissue, to recover their normal function over the weeks that follow.
The downstream payoff of better energy and repair is steadier signaling. As mitochondrial function and repair pathways recover, the dopamine and serotonin systems that substance use threw off balance have the support they need to begin to normalize. Clinically, that can show up as better sleep, less anxiety, and quicker cognitive recovery, all of which make it easier for a person to engage with counseling and the rest of their plan.
NAD+ is most often given as a slow intravenous infusion, an approach that sits alongside other modern bio-hacking approaches that some luxury programs offer. There is no single standardized protocol, but most share a few features.
The mechanistic case for NAD+ is genuinely strong; the clinical case is still early. Most human studies to date are small, observational, or case series rather than large, blinded, randomized controlled trials, which are the gold standard for proving a treatment works.
Several limitations make firm conclusions difficult. Protocols vary widely between clinics, outcomes often rely on self-report, and co-interventions like nutrition and counseling are bundled in, making it hard to isolate what NAD+ itself contributes. Systematic reviews tend to stress plausibility while calling for better-powered trials.
Placebo is a particular challenge. The ritual of an infusion and the attentive clinical setting can themselves produce real, expectation-driven improvement. Separating that from a true biochemical effect requires sham-controlled designs that are difficult to run but necessary to settle the question.
None of this means NAD+ is without value. It means the sensible posture is cautious optimism: use it where it appears to help, measure outcomes honestly, and prioritize integration with treatments that already carry strong evidence rather than leaning on NAD+ alone.
It also helps to set expectations directly with patients. Honest framing, that NAD+ may ease symptoms and support engagement but is not a proven cure, protects against both disappointment and overspending, and it keeps attention on the therapies most likely to sustain recovery. That kind of candor is itself part of good care.
As one of several holistic therapies and alternative treatments used in addiction care, NAD+ suits some people better than others, and a few safety considerations should guide its use.
NAD+ is a platform, not a solution. Its job is to stabilize physiology so that the real work of recovery can begin, which means it belongs inside a broader plan rather than standing in for one.
Counseling should start early and continue after the infusions end. Cognitive behavioral therapy, motivational interviewing, and relapse-prevention planning are natural partners, and pairing them with nutritional therapy reinforces the same metabolic recovery NAD+ is meant to support.
Coordination is what makes the gains stick. Medical staff oversee the infusions, therapists handle the behavioral work, and case managers attend to the social supports, so a short biochemical boost becomes part of a durable recovery platform rather than an isolated event.
Practically, that also means measuring what matters. Tracking craving, sleep, mood, and day-to-day functioning shows whether NAD+ is helping a given person, and it ensures that any short-term improvement is translated into lasting change through ongoing therapy and support.
Carrara Treatment Wellness & Spa integrates medically supervised detox, advanced wellness therapies, and evidence-based clinical care, so that approaches like NAD+ are delivered safely and as part of a complete plan. As a Joint Commission accredited provider with three private estates across Southern California and acceptance of more than 14 insurance providers, Carrara coordinates medically supervised detox, wellness therapies, and behavioral care within a single program tailored to the individual. Take the first step toward recovery.
Britney Elyse has over 15 years experience in mental health and addiction treatment. Britney completed her undergraduate work at San Francisco State University and her M.A. in Clinical Psychology at Antioch University. Britney worked in the music industry for several years prior to discovering her calling as a therapist. Britney’s background in music management, gave her first hand experience working with musicians impacted by addiction. Britney specializes in treating trauma using Somatic Experiencing and evidence based practices. Britney’s work begins with forming a strong therapeutic alliance to gain trust and promote change. Britney has given many presentations on somatic therapy in the treatment setting to increase awareness and decrease the stigma of mental health issues. A few years ago, Britney moved into the role of Clinical Director and found her passion in supervising the clinical team. Britney’s unique approach to client care, allows us to access and heal, our most severe cases with compassion and love. Prior to join the Carrara team, Britney was the Clinical Director of a premier luxury treatment facility with 6 residential houses and an outpatient program